Editorial: choosing an appropriate risk stratification tool for nonalcoholic fatty liver disease—one size does not fit all

Abstract

LINKED CONTENTThis article is linked to Kang et al and Jun and Nguyen papers. To view these articles, visit https://doi.org/10.1111/apt.15626 and https://doi.org/10.1111/apt.15651

Editorial: choosing an appropriate risk stratification tool for nonalcoholic fatty liver disease—one size does not fit all. Authors' reply

“…We appreciate the opportunity to reply to the valid points that Shaheen and Swain raised about our recent study on the use of magnetic resonance elastography (MRE) to determine the presence of fibrosis in the general population and those with NAFLD . In particular, they pointed out that MRE is an expensive technology that is not as readily available in clinical practice settings as ultrasound or serum biomarkers which weakens our study results.…”

Editorial: The tsunami of steatotic liver disease in India, the Asia‐Pacific region and the world—Authors' reply

“…We thank Shaheen et al. for their editorial 1 on our recent publication in AP&T 2 . We appreciate the thoughtful consideration and incisive interpretation of our paper.…”